A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.

by Brad Jones

In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

by Brad Jones

Patients who opt for breast reconstruction after mastectomy tend to overestimate how happy they will be with the results, while those who do not get reconstruction tend to underestimate their future satisfaction.

by Cici Zhang

Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

by Cheryl Platzman Weinstock

Q&A

Research scientist Teresa Woodruff is determined to make fertility preservation accessible to more young adults and children with cancer.

by Delia O'Hara

Forward Look

Efforts are underway to define role of high-dose radiation.

by Stephen Ornes

Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.

by Sue Rochman

Survivor Profile

After Shigeo Tsuruoka was diagnosed with stomach cancer, his family came together to help him. His daughter, Aki Smith, was by his side as he navigated treatment and recovery. Now she offers guidance to other stomach cancer patients and caregivers.

by Kate Yandell

A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.

by Marci A. Landsmann

Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.

by Kate Yandell